MOSCOW, October 17 (Reuters): The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVI
Saturday, 20th September, 2025
